Clinical trials for children with cancer in Europe - still a long way from harmonisation: a report from SIOP Europe.

[1]  B. Geoerger,et al.  A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: a European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG). , 2008, European journal of cancer.

[2]  Maria Grazia Valsecchi,et al.  Improving recruitment to clinical trials for cancer in childhood. , 2008, The Lancet. Oncology.

[3]  C. Mitchell.  Clinical trials in paediatric haematology-oncology: are future successes threatened by the EU directive on the conduct of clinical trials? , 2007, Archives of Disease in Childhood.

[4]  E. Cannell.  Clinical Trials Directive slows registration of paediatric studies. , 2007, The Lancet. Oncology.

[5]  R. Sullivan,et al.  The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK. , 2007, European journal of cancer.

[6]  E. Steliarova-Foucher,et al.  Cancer in children and adolescents in Europe: developments over 20 years and future challenges. , 2006, European journal of cancer.

[7]  P. Kellokumpu-Lehtinen,et al.  Harmful impact of EU clinical trials directive , 2006, BMJ : British Medical Journal.

[8]  A. Baeyens.  Impact of the European Clinical Trials Directive on academic clinical research. , 2004, Medicine and law.

[9]  C. R. Pinkerton,et al.  Recruiting children into cancer trials–role of the United Kingdom Children's Cancer Study Group (UKCCSG) , 2003, British Journal of Cancer.